TYRA (Tyra Biosciences) OCF Yield %: -5.39 (As of Jun. 27, 2026)


TYRA Tyra Biosciences Inc TYRA
28 GF Score
Price $31.88
! 2 Warning Signs
View Full Analysis

What is Tyra Biosciences OCF Yield %?

Tyra Biosciences TYRA +3.07% 28 OCF Yield % is -5.39 as of Jun. 27, 2026. GuruFocus rates TYRA with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 1,419 Biotechnology companies, Tyra Biosciences ranks better than 57.58% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Tyra Biosciences's Trailing 12-Month Cash Flow from Operations is $-102.26 Mil, and Market Cap is $1,895.92 Mil. Therefore, Tyra Biosciences's OCF Yield % for today is -5.39%.

The historical rank and industry rank for Tyra Biosciences's OCF Yield % or its related term are showing as below:

TYRA' s OCF Yield % Range Over the Past 10 Years
Min: -5.69   Med: 0   Max: -5.35
Current: -5.39


During the past 7 years, the highest OCF Yield % of Tyra Biosciences was -5.35%. The lowest was -5.69%. And the median was %.

TYRA's OCF Yield % is ranked better than
57.58% of 1419 companies
in the Biotechnology industry
Industry Median: -8.48 vs TYRA: -5.39

Tyra Biosciences's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Tyra Biosciences OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Tyra Biosciences OCF Yield % Related Terms


Tyra Biosciences OCF Yield % Historical Data

* Premium members only.

The historical data trend for Tyra Biosciences's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tyra Biosciences OCF Yield % Chart

Tyra Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial -4.07 -15.62 -8.41 -9.89 -6.74

Tyra Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.62 -18.59 -12.00 -6.69 -5.72

TYRA vs ZLAB, OCUL, AUPH: OCF Yield % Comparison

For the Biotechnology subindustry, Tyra Biosciences's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tyra Biosciences OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tyra Biosciences's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Tyra Biosciences's OCF Yield % falls into.


TYRA
28GF Score
Tyra Biosciences Inc TYRA
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tyra Biosciences OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Tyra Biosciences's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-95.142 / 1411.93074
=-6.74%

Tyra Biosciences's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-32.571 * 4 / 2277.701
=-5.72%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -5.39 mean?
Tyra Biosciences (TYRA) has a OCF Yield % of -5.39 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Tyra Biosciences and its competitors. According to the industry distribution chart, Tyra Biosciences ranks #602 out of 1419 companies in the Biotechnology industry, placing it in the top 42.4%.
Is Tyra Biosciences' OCF Yield % too high?
Tyra Biosciences' current OCF Yield % is -5.39. Based on the distribution chart, Tyra Biosciences ranks #602 out of 1419 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Tyra Biosciences has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Tyra Biosciences' OCF Yield % compare to ZLAB and OCUL?
According to the Biotechnology industry distribution chart, Tyra Biosciences ranks #602 out of 1419 companies for OCF Yield %. This puts Tyra Biosciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Tyra Biosciences and its competitors. Tyra Biosciences's current OCF Yield % is -5.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tyra Biosciences stock overvalued right now?
Tyra Biosciences (TYRA) has a current OCF Yield % of -5.39. The current OCF Yield % is -5.39. Tyra Biosciences' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Tyra Biosciences (TYRA), the current OCF Yield % is -5.39 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tyra Biosciences Business Description

Address 2656 State Street, Carlsbad, CA, USA, 92008
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
28GF Score

Get the complete analysis for TYRA

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.88
Price